Home Newsfeeds Evercore ISI Group Initiates Coverage On Mineralys Therapeutics with Outperform Rating

Evercore ISI Group Initiates Coverage On Mineralys Therapeutics with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.

byBenzinga Newsdesk

March 7, 2023

1 minute read

Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.

Zai Lab Q4 EPS $(0.46) Up From $(2.24) YoY

By Benzinga Newsdesk

March 1, 5:07 PM

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.46) per share. This is a 79.46 percent increase over losses of $(2.24) per share from the same period last year.

ZLAB

Kohl’s Affirms FY23 Outlook

By Benzinga Newsdesk

May 24, 7:03 AM

2023 Financial and Capital Allocation Outlook For the full year 2023, the Company affirms its financial outlook and currently expects the following: Net sales: A decrease of (2%) to (4%), includes

KSS

T2 Biosystems Q2 EPS $(0.10) Down From $(0.08) YoY, Sales $5.90M Miss $6.13M Estimate

By Benzinga Newsdesk

August 15, 4:10 PM

T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.10) per share. This is a 25 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $5.90

TTOO

Global
News

Jefferies And SMBC Expand Strategic Alliance To Canada

By Benzinga Newsdesk

April 4, 8:17 AM

Jefferies Financial Group Inc. (NYSE:JEF) ("Jefferies") and SMBC Group announced today that they have expanded their global strategic alliance to enhance collaboration on future corporate and investment banking business

EWC

Evercore ISI Group Initiates Coverage On Mineralys Therapeutics with Outperform Rating

Related Posts

Zai Lab Q4 EPS $(0.46) Up From $(2.24) YoY

Kohl’s Affirms FY23 Outlook

T2 Biosystems Q2 EPS $(0.10) Down From $(0.08) YoY, Sales $5.90M Miss $6.13M Estimate

Jefferies And SMBC Expand Strategic Alliance To Canada